INKON Life Technology Co., Ltd. (SHE:300143)

Market Cap	6.68B
Revenue (ttm)	1.55B
Net Income (ttm)	119.19M
Shares Out	743.29M
EPS (ttm)	0.18
PE Ratio	50.30
Forward PE	47.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,484,000
Average Volume	4,690,601
Open	9.31
Previous Close	9.10
Day's Range	8.98 - 9.31
52-Week Range	6.91 - 11.39
Beta	1.11
RSI	37.67
Earnings Date	Aug 22, 2025

About INKON Life Technology

INKON Life Technology Co., Ltd. focuses on building an ecological platform for chain of pre-diagnosis/treatment/health providing medical services for tumors in China and internationally. The company engages in the research, development, innovation, and services of scenarios and equipment medical devices. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology Co., Ltd. was founded in 1998 and is headquartered in Qingdao, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 2,207
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300143

Financial Performance

In 2024, INKON Life Technology's revenue was 1.56 billion, an increase of 6.01% compared to the previous year's 1.47 billion. Earnings were 115.42 million, an increase of 14.92%.